(Q34203535)

31 July 2017

1 reference

title

Cholecystokinin antagonists: pharmacological and therapeutic potential (English)

1 reference

31 July 2017

1 reference

1 reference

Rosario Herranz

1

1 reference

PubMed ID

12789687

31 July 2017

language of work or name

1 reference

1 September 2003

1 reference

Medicinal Research Reviews

31 July 2017

1 reference

31 July 2017

23

1 reference

31 July 2017

5

1 reference

31 July 2017

559-605

1 reference

Cloning and expression of the rabbit gastric CCK-A receptor

31 July 2017

1 reference

Analysis of variation in L-365,260 competition curves in radioligand binding assays

21 January 2018

1 reference

COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists

21 January 2018

1 reference

Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists

21 January 2018

1 reference

2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist

21 January 2018

1 reference

Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain.

21 January 2018

1 reference

Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications

21 January 2018

1 reference

The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans

21 January 2018

1 reference

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

21 January 2018

1 reference

Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260

21 January 2018

1 reference

New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.

21 January 2018

1 reference

Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419

21 January 2018

1 reference

Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II.

21 January 2018

1 reference

Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist

21 January 2018

1 reference

Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. III. Structural elucidation

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.18

Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. II. Isolation, characterization and biological activities

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.11

Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.38.1633

Identifiers

DOI

10.1002/MED.10042

1 reference

31 July 2017

1 reference

PubMed ID

12789687